Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Complex genomic rearrangement of chromosome 16p13.3 detected by array comparative genomic hybridization in a patient with multiple congenital anomalies, dysmorphic craniofacial features, and developmental delay.

Gu J, Sreenath Nagamani SC, Hopwood VL, Sanchez B, Saeidinejad Y, Ou Z, Peacock S, Grange DK, Stankiewicz P, Cheung SW.

Am J Med Genet A. 2011 Oct;155A(10):2589-92. doi: 10.1002/ajmg.a.34185. Epub 2011 Sep 9. No abstract available.

PMID:
21910221
2.

Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.

Wang Y, Hopwood VL, Hu P, Lennon A, Osterberger J, Glassman A.

Cancer Genet Cytogenet. 2004 Aug;153(1):53-6.

PMID:
15325094
3.

Color banding.

Hopwood VL, Hada CJ, Glassman AB.

Methods Mol Biol. 2002;204:133-42. No abstract available.

PMID:
12397795
4.

Correlation of non-random chromosomal aberrations in lymphocytes of prostate cancer patients with specific clinical parameters.

Ozen M, Hopwood VL, Balbay MD, Johnston DA, Babaian RJ, Logothetis CJ, von Eschenbach AC, Pathak S.

Int J Oncol. 2000 Jul;17(1):113-7.

PMID:
10853027
5.

Amplification of the Y chromosome in three murine tumor cell lines transformed in vivo by different human prostate cancers.

Multani AS, Ozen M, Agrawal A, Hopwood VL, von Eschenbach AC, Pathak S.

In Vitro Cell Dev Biol Anim. 1999 Apr;35(4):236-9.

PMID:
10478804
6.

Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancer.

Ozen M, Hopwood VL, Johnston DA, Babaian RJ, Logothetis CJ, von Eschenbach AC, Pathak S.

Urology. 1999 Feb;53(2):381-5.

PMID:
9933059
7.

DNA repair and mutagen sensitivity in patients with triple primary cancers.

Miller DG, Tiwari R, Pathak S, Hopwood VL, Gilbert F, Hsu TC.

Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):321-7.

8.

Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia.

Glassman AB, Harper-Allen EA, Hayes KJ, Hopwood VL, Gutterman EE, Zagryn SP.

Ann Clin Lab Sci. 1998 Jan-Feb;28(1):24-9.

PMID:
9512781
9.

A modified fluorescence in situ hybridization (FISH) technique.

Multani AS, Hopwood VL, Pathak S.

Anticancer Res. 1996 Nov-Dec;16(6B):3435-7.

PMID:
9042203
10.

Non-random primary and secondary chromosomal abnormalities in human gastric cancers.

Yadav M, Hopwood VL, Multani AS, Mansfield PF, Takahashi Y, McIntyre BW, Udagawa T, Pathak S.

Anticancer Res. 1996 Jul-Aug;16(4A):1787-95.

PMID:
8712702
11.

Sex chromosome abnormalities in lung cancer patients.

Dave BJ, Hopwood VL, Spitz MR, Pathak S.

Cancer Genet Cytogenet. 1996 Mar;87(1):24-8.

PMID:
8646735
12.

Ag-NOR studies in a human lymphocyte culture: are variants localized to specific chromosomes?

Ozen M, Hopwood VL, Pathak S.

Am J Med Genet. 1995 Nov 6;59(2):225-8.

PMID:
8588590
13.

Integrin-mediated entry into S phase of human gastric adenocarcinoma cells.

Udagawa T, Hopwood VL, Pathak S, McIntyre BW.

Clin Exp Metastasis. 1995 Nov;13(6):427-38.

PMID:
7586801
14.

Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis.

Dave BJ, Hopwood VL, King TM, Jiang H, Spitz MR, Pathak S.

Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):743-9. Erratum in: Cancer Epidemiol Biomarkers Prev 1995 Dec;4(8):910. Ziang H [corrected to Jiang H].

15.

Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient.

Gagos S, Hopwood VL, Iliopoulos D, Kostakis A, Karayannakos P, Yatzides H, Skalkeas GD, Pathak S.

Anticancer Res. 1995 Mar-Apr;15(2):369-78.

PMID:
7763008
16.

Improved quality of Giemsa banding by the use of trypsin concentrate.

Hopwood VL, Pathak S.

Am Biotechnol Lab. 1994 Oct;12(11):52. No abstract available.

PMID:
7765426
17.

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW.

Cancer Res. 1994 May 15;54(10):2577-81. Erratum in: Cancer Res 1994 Jul 15;54(14):3953.

18.

Nonrandom chromosomal abnormalities in lymphocyte cultures of individuals with colorectal polyps and of asymptomatic relatives of patients with colorectal cancer or polyps.

Dave BJ, Hopwood VL, Hughes JI, Mellilo D, Jackson GL, Pathak S.

Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):587-91.

19.

Cytogenetic abnormalities in colon cancer patients: a comparison of T- and B-lymphocytes.

Dave BJ, Hopwood VL, Hughes JI, Jackson GL, Melillo D, Pathak S.

Anticancer Res. 1993 Mar-Apr;13(2):433-8.

PMID:
8517659
20.

Induction of chromosomal rearrangement by tumor necrosis factors produced by primary B lymphoblastoid cells derived from cancer patients.

Aggarwal BB, Gadhia PK, Hopwood VL, Dave BJ, Risin S, Owen-Schaub L, Pandita R, Pathak S.

Lymphokine Cytokine Res. 1993 Feb;12(1):9-19.

PMID:
8457633
21.
22.
23.

Is ribosomal cistron activity increased in human lymphoblastoid cell lines?

Gupta NJ, Hopwood VL, Pathak S.

In Vivo. 1992 Mar-Apr;6(2):125-8.

PMID:
1525331
24.

Identification of colon cancer-predisposed individuals: a cytogenetic analysis.

Pathak S, Hopwood VL, Hughes JI, Jackson GL.

Am J Gastroenterol. 1991 Jun;86(6):679-84.

PMID:
2038988
25.

Chromosome anomalies in human breast cancer: evidence for specific involvement of 1q region in lymphocyte cultures.

Pathak S, Hopwood VL, Hortobagyi GN, Jackson GL, Hughes JI, Melillo D.

Anticancer Res. 1991 May-Jun;11(3):1055-60.

PMID:
1888138
26.

Cytogenetic characterization of eight human lymphoblastoid cell lines.

Gupta NJ, Hopwood VL, Sahasrabuddhe CG, Furukawa K, Pathak S.

In Vivo. 1991 Jan-Feb;5(1):17-22.

PMID:
1932619
27.

Genetic susceptibility, somatic mosaicisms and predisposition to human cancer.

Pathak S, Dhaliwal MK, Hopwood VL.

Anticancer Res. 1989 Jan-Feb;9(1):17-9.

PMID:
2539769

Supplemental Content

Loading ...
Support Center